New Federal Incentives for Diversity in Clinical Trials.

Hwang, Thomas J; Brawley, Otis W

Hwang, Thomas J; Brawley, Otis W.

Hwang TJ; From the Division of Urological Surgery, Brigham and Women's Hospital, and the Cancer Innovation and Regulation Initiative, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - both in Boston (T.J.H.); and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, and the Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health - both in Baltimore (O.W.B.).
Brawley OW; From the Division of Urological Surgery, Brigham and Women's Hospital, and the Cancer Innovation and Regulation Initiative, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - both in Boston (T.J.H.); and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, and the Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health - both in Baltimore (O.W.B.).

N Engl J Med ; 387(15): 1347-1349, 2022 10 13.

Article in English | MEDLINE | ID: covidwho-2186515

Subject(s)

Clinical Trials as Topic; Cultural Diversity; Federal Government; Motivation; Humans; Clinical Trials as Topic/standards; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / Cultural Diversity / Federal Government / Motivation Type of study: Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: N Engl J Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google